Natural Killer Cells in the Liver and Their Activators

  • Masatoshi Tanaka
  • Miki Shirachi
  • Masahiro Shimada
  • Yoshihiro Shimauchi
  • Ryoko Kuromatsu
  • Michio Sata
  • Kyuichi Tanikawa
Conference paper

Summary

An impaired host defense mechanism is well known in patients with liver cirrhosis. To clarify the sight of natural resistance in the liver, we investigated hepatic natural killer (NK) activity, and a proportion of the NK cells in the hepatic sinusoids of normal and cirrhotic rats. Using a sinusoidal lavage method, liver-associated lymphocytes were obtained from normal and cirrhotic rats that were established using thioacetamide. NK activity was measured by 51Cr-release assay, and the NK cell count was measured by flow cytometric analysis using monoclonal antibodies. In addition, OK432 (a pharmaceutical preparation of α-Streptococcus pyrogens), Shosaiko-to (a Chinese herbal medicine), and interferon-α were administered to experimental rats and the subsequent changes in hepatic NK activity and the NK cell count were also observed. Not only hepatic NK activity, but also the proportion of hepatic NK cells were significantly lower in cirrhotic rats than in control rats. Hepatic NK activity and NK cell count in the liver increased significantly after the administration of NK cell activators such as OK432 and Sho-saiko-to. After the administration of interferon-α, there was also as increase in the previously reduced hepatic NK activity and NK cell count of cirrhotic rats. The results of this study may lead to a clearer understanding of the host defense mechanism in cirrhotic patients.

Key words

Hepatic NK activity NK cell OK432 Sho-saiko-to IFN-α 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tanaka M, Ogata H, Yoshimoto K, et al. (1989) Harvest of liver sinusoidal large granular lymphocytes (pit cells) and augmentation of natural killer activity by the administration of OK432. Cells Hepatic Sinusoid 2:451–455Google Scholar
  2. 2.
    Kaneda K, Dan C, Wake K (1983) Pit cells as natural killer cells. Biomed Res 4:567–576Google Scholar
  3. 3.
    Wisse E, Noordende JM, van derMeulen J, et al. (1976) The pit cells: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 173:423–435PubMedCrossRefGoogle Scholar
  4. 4.
    Wiltrout RH, Mathieson BJ, Talmadge JE, et al. (1984) Augmentation of organassociated natural killer activity by biological response modifiers. J Exp Med 160:1431–1449PubMedCrossRefGoogle Scholar
  5. 5.
    Budzynski W, Chirigos M, Gruy E (1987) Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2. Cancer Immunol Immunother 24:253–258PubMedCrossRefGoogle Scholar
  6. 6.
    Vanderkerken K, Bowens L, Van BK, et al. (1993) Origin and differentiation of hepatic natural killer cells (pit cells). Hepatology 22:919–925CrossRefGoogle Scholar
  7. 7.
    Vanderkerken K, Bowens L, Wisse E (1990) Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids. Hepatology 12:70–75PubMedCrossRefGoogle Scholar
  8. 8.
    Bukowski JF, Wada BA, Habu S, et al. (1983) Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 131:1531–1538PubMedGoogle Scholar
  9. 9.
    Welsh RM, Brubaker JO, Vargas CM, et al. (1991) Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 173:1053–1063PubMedCrossRefGoogle Scholar
  10. 10.
    Liaw YF, Lee CS, Tai SL, et al. (1995) T cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22:1368–1373PubMedGoogle Scholar
  11. 11.
    Poralla T, Hutteroth TH, Meyer BK (1984) Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis. Gut 25:114–120PubMedCrossRefGoogle Scholar
  12. 12.
    Uchida A, Micksche M (1983) Intrapleural administration of OK432 in cancer patients. Int J Cancer 31:1–5PubMedCrossRefGoogle Scholar
  13. 13.
    Bouwens L, Remels L, Baekeland M, et al. (1987) Large granular lymphocytes or “pit cells” from rat liver: isolation, ultrastructural characterization and natural killer activity. Eur J Immunol 17:37–42PubMedCrossRefGoogle Scholar
  14. 14.
    Reynolds C, Sharrow S, Ortaldo J, et al. (1981) Natural killer activity in the rat. II. Analysis of surface antigen on LGL by flow cytometry. J Immunol 127:2204–2208PubMedGoogle Scholar
  15. 15.
    Uchida A, Micksche M (1981) In vitro augmentation of natural killing activity by OK432. Int J Immunopharmacol 3:365–375PubMedCrossRefGoogle Scholar
  16. 16.
    Kawaguchi T, Suematsu M, Koizumi M, et al. (1983) Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK432. Int J Immunopharmacol 6:177–189Google Scholar
  17. 17.
    Shimauchi Y, Tanaka M, Yoshitake M, et al. (1993) Functional differences between rat Kupffer cells and splenic macrophages. Cells Hepatic Sinusoid 4:198–200Google Scholar
  18. 18.
    Oka H, Yamamoto S, Kuroki T, et al. (1995) Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to. Cancer 76:743–749PubMedCrossRefGoogle Scholar
  19. 19.
    Shimada M, Tanaka M, Shimauchi Y, et al. (1993) Oral administration of Sho-saiko-to (TJ-9, Japanese herbal medicine) enhanced liver-associated natural killer activity. Cells Hepatic Sinusoid 4:536–537Google Scholar
  20. 20.
    Carpentier B, Franco D, Paci L, et al. (1984) Deficient natural killer cell activity in alcoholic cirrhosis. Clin Exp Immunol 58:107–115Google Scholar
  21. 21.
    Chuang WL, Liu HW, Chang WY (1990) Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer 65:926–930PubMedCrossRefGoogle Scholar
  22. 22.
    Laso FJ, Madruga JI, Gioron JA, et al. (1997) Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcoholic liver disease but not active ethanol consumption. Hepatology 25:1096–1100PubMedCrossRefGoogle Scholar
  23. 23.
    Zimmermann T, Muller A, Machnik G, et al. (1987) Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats. Z Versuchstierkd 30(5–6):165–180PubMedGoogle Scholar
  24. 24.
    Shirachi M, Sata M, Miyajima I, et al. (1998) Liver-associated natural killer activity in cirrhotic rats. Microbiol Immunol 42:117–124PubMedGoogle Scholar
  25. 25.
    Bouwens L, Wisse E (1987) Immuno-electron microscopic characterization of large granular lymphocytes (natural killer cells) from rat liver. Eur J Immunol 17:1423–1428PubMedCrossRefGoogle Scholar
  26. 26.
    Luo D, Vanderkerken K, Bouwens L, et al. (1995) The number and distribution of hepatic natural killer cells (pi cells) in normal rat liver: an immunohistochemical study. Hepatology 21:1690–1694PubMedGoogle Scholar
  27. 27.
    Vanderkerken K, Bowens L, De NW, et al. (1993) Origin and differentiation of hepatic natural killer cells (pit cells). Hepatology 18:919–925PubMedCrossRefGoogle Scholar
  28. 28.
    Arii S, Monden K, Itai S, et al. (1990) Depressed function of Kupffer cells in rats with CCL4-induced liver cirrhosis. Res Exp Med Berl 190:173–182PubMedCrossRefGoogle Scholar
  29. 29.
    Lough J, Rosenthall L, Arzoumanian A, et al. (1987) Kupffer cell depletion associated with capillarization of liver sinusoids in carbon tetrachloride-induced rat liver cirrhosis. J Hepatol 5:190–198PubMedCrossRefGoogle Scholar
  30. 30.
    Actis G, Ponzetto A, D’Urso N, et al. (1991) Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid. Liver 11:106–113PubMedGoogle Scholar
  31. 31.
    Amagai T, Kita M, Imanishi J, et al. (1983) Augmentation of natural killer activity of human peripheral blood lymphocytes by human leukocytes by human leukocyte inter-feron: characterization of the augmented activity. Gann (Jpn J Cancer Res) 74:887–895Google Scholar
  32. 32.
    Castilla A, Camps-Bansell J, Civeira M, et al. (1993) Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study. Am J Gastroenterol 88:233–239PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1999

Authors and Affiliations

  • Masatoshi Tanaka
    • 1
  • Miki Shirachi
    • 1
  • Masahiro Shimada
    • 1
  • Yoshihiro Shimauchi
    • 1
  • Ryoko Kuromatsu
    • 1
  • Michio Sata
    • 1
  • Kyuichi Tanikawa
    • 1
  1. 1.The Second Department of Internal MedicineKurume University School of MedicineKurume, FukuokaJapan

Personalised recommendations